# Anja Schiel

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/anja-schiel/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,062 |
| Field | Health Systems, Economic Evaluations, Quality of Life |
| h-index | 17 |
| i10-index | 23 |
| Last Known Institution | Direktoratet for medisinske produkter |
| OpenAlex ID | https://openalex.org/A5049715232 |
| ORCID iD | 0000-0002-1258-4731 |
| Works | 45 |

## Researcher papers

- [Induction of Thyroid Hormone-Degrading Deiodinase in Cardiac Hypertrophy and Failure](https://scholariq.org/papers/induction-of-thyroid-hormone-degrading-deiodinase-in-cardiac-hypertrophy-and/)
- [Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure](https://scholariq.org/papers/microarray-analysis-reveals-pivotal-divergent-mrna-expression-profiles-early-in/)
- [Current Statistical Considerations and Regulatory Perspectives on the Planning of Confirmatory Basket, Umbrella, and Platform Trials](https://scholariq.org/papers/current-statistical-considerations-and-regulatory-perspectives-on-the-planning/)
- [The use of external controls: To what extent can it currently be recommended?](https://scholariq.org/papers/the-use-of-external-controls-to-what-extent-can-it-currently-be-recommended/)
- [Intrauterine Exposure to Maternal Atherosclerotic Risk Factors Increases the Susceptibility to Atherosclerosis in Adult Life](https://scholariq.org/papers/intrauterine-exposure-to-maternal-atherosclerotic-risk-factors-increases-the/)
- [Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures](https://scholariq.org/papers/setting-international-standards-in-analyzing-patient-reported-outcomes-and/)
- [Alternatively spliced forms of the human myeloid Fcα receptor (CD89) in neutrophils](https://scholariq.org/papers/alternatively-spliced-forms-of-the-human-myeloid-fc-receptor-cd89-in-neutrophils/)
- [The impact of parallel regulatory–health technology assessment scientific advice on clinical development. Assessing the uptake of regulatory and health technology assessment recommendations](https://scholariq.org/papers/the-impact-of-parallel-regulatory-health-technology-assessment-scientific-advice/)
- [Single‐Arm Clinical Trials as Pivotal Evidence for Cancer Drug Approval: A Retrospective Cohort Study of Centralized European Marketing Authorizations Between 2010 and 2019](https://scholariq.org/papers/single-arm-clinical-trials-as-pivotal-evidence-for-cancer-drug-approval-a/)
- [Collaborative Platform Trials to Fight COVID‐19: Methodological and Regulatory Considerations for a Better Societal Outcome](https://scholariq.org/papers/collaborative-platform-trials-to-fight-covid-19-methodological-and-regulatory/)
- [Can we use existing guidance to support the development of robust real-world evidence for health technology assessment/payer decision-making?](https://scholariq.org/papers/can-we-use-existing-guidance-to-support-the-development-of-robust-real-world/)

## Researcher topics

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Statistical Methods in Clinical Trials](https://scholariq.org/topics/statistical-methods-in-clinical-trials/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Biomedical Ethics and Regulation](https://scholariq.org/topics/biomedical-ethics-and-regulation/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)

## Researcher university

- [Direktoratet for medisinske produkter](https://scholariq.org/institutions/direktoratet-for-medisinske-produkter/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
